Matches in Wikidata for { <http://www.wikidata.org/entity/Q94153954> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q94153954 description "article scientifique publié en 2018" @default.
- Q94153954 description "wetenschappelijk artikel" @default.
- Q94153954 description "наукова стаття" @default.
- Q94153954 name "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 name "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 type Item @default.
- Q94153954 label "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 label "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 prefLabel "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 prefLabel "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 P1433 Q94153954-E25667B7-9241-4958-8EA9-0586D3500F91 @default.
- Q94153954 P1476 Q94153954-22D265A1-08D6-45FD-B975-6703CB9D6249 @default.
- Q94153954 P2093 Q94153954-1DE37D85-1CDD-40E3-AB6A-1D711E973E9C @default.
- Q94153954 P2093 Q94153954-2020585A-3538-4C2D-9862-8D82A4DB66AB @default.
- Q94153954 P2093 Q94153954-257852A9-2835-4B01-9457-9DA8E8F7D152 @default.
- Q94153954 P2093 Q94153954-2A4C1F61-1C3B-4365-BFE8-439D24C88B83 @default.
- Q94153954 P2093 Q94153954-2F0ACAA7-8589-4955-A80C-FA82864A1C63 @default.
- Q94153954 P2093 Q94153954-441C3C58-0561-445F-A75C-37FDBDDD7616 @default.
- Q94153954 P2093 Q94153954-588AC48E-E3D6-4771-9297-EECAC2FB3381 @default.
- Q94153954 P2093 Q94153954-6411233C-7524-4CEA-B5CF-0BBD5D01FCB7 @default.
- Q94153954 P2093 Q94153954-644710F7-05D0-41D8-B4D4-B3B47F48485C @default.
- Q94153954 P2093 Q94153954-7B350A86-8E3C-4A52-BC1F-806CE54C58D7 @default.
- Q94153954 P2093 Q94153954-90D62A11-E0B6-4B5F-BDDE-86161E8E80C9 @default.
- Q94153954 P2093 Q94153954-A59DEA32-A3A0-4C74-983D-9922CF829F8C @default.
- Q94153954 P2093 Q94153954-A953FA18-AE5A-4584-8650-0B92EAE5F076 @default.
- Q94153954 P2093 Q94153954-C11D1150-4BB3-43E9-A1F6-1D9990A7F3C5 @default.
- Q94153954 P2093 Q94153954-C2ECB1F5-1B56-4062-AE0E-E8C9603C5AC5 @default.
- Q94153954 P2093 Q94153954-D6D9517F-48AB-49BF-B769-47091397F3A0 @default.
- Q94153954 P2093 Q94153954-E8A08252-A415-4B7A-8A55-DE9292ADBD59 @default.
- Q94153954 P2093 Q94153954-F2656FE2-D470-451B-B88B-4F075C2BBD2E @default.
- Q94153954 P2093 Q94153954-FC89E977-5FFA-4B83-A7C0-0C6B2C1982F9 @default.
- Q94153954 P304 Q94153954-286DD26C-6DFA-4062-A966-48711170E06D @default.
- Q94153954 P31 Q94153954-A434E3D7-01E8-4F30-A086-BBC979188DD8 @default.
- Q94153954 P356 Q94153954-59C061F6-061A-41DA-B685-55A19764163C @default.
- Q94153954 P433 Q94153954-A67B0AE3-1282-41FF-830D-5758E177C151 @default.
- Q94153954 P478 Q94153954-F3BB04F1-7A55-4F1D-AC51-32B4BE23DC27 @default.
- Q94153954 P50 Q94153954-33E0D008-E815-48F1-AC07-C14A81009C89 @default.
- Q94153954 P50 Q94153954-8B2091C4-F79B-406B-8E0B-0FE02CC468CC @default.
- Q94153954 P50 Q94153954-BA906C86-1DCE-4A4A-A55F-06FE8B6A1C85 @default.
- Q94153954 P577 Q94153954-F5A91E3B-CF88-4380-9653-72304F13EEA3 @default.
- Q94153954 P932 Q94153954-CE95ECAD-111C-4918-90F0-BD5644F2BC1D @default.
- Q94153954 P356 NOY148.973 @default.
- Q94153954 P1433 Q15724471 @default.
- Q94153954 P1476 "RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA" @default.
- Q94153954 P2093 "Alexander Lin" @default.
- Q94153954 P2093 "Benjamin Ellingson" @default.
- Q94153954 P2093 "Bin Wu" @default.
- Q94153954 P2093 "Brandon Nicolay" @default.
- Q94153954 P2093 "Brian Soher" @default.
- Q94153954 P2093 "Changho Choi" @default.
- Q94153954 P2093 "Elizabeth Maher" @default.
- Q94153954 P2093 "Feng Yin" @default.
- Q94153954 P2093 "Ingo Mellinghoff" @default.
- Q94153954 P2093 "Jennifer Clarke" @default.
- Q94153954 P2093 "Katharine Yen" @default.
- Q94153954 P2093 "Katherine Peters" @default.
- Q94153954 P2093 "Kha Le" @default.
- Q94153954 P2093 "Lori Steelman" @default.
- Q94153954 P2093 "Min Lu" @default.
- Q94153954 P2093 "Shuchi Pandya" @default.
- Q94153954 P2093 "Steven Schoenfeld" @default.
- Q94153954 P2093 "Yan Li" @default.
- Q94153954 P2093 "Yanwei Zhang" @default.
- Q94153954 P304 "vi234-vi234" @default.
- Q94153954 P31 Q13442814 @default.
- Q94153954 P356 "10.1093/NEUONC/NOY148.973" @default.
- Q94153954 P433 "Suppl 6" @default.
- Q94153954 P478 "20" @default.
- Q94153954 P50 Q105531697 @default.
- Q94153954 P50 Q42725064 @default.
- Q94153954 P50 Q47159504 @default.
- Q94153954 P577 "2018-11-05T00:00:00Z" @default.
- Q94153954 P932 "6217633" @default.